Abstract:Khaled S Allemailem, 1 Ahmad Almatroudi, 1 Arshad Husain Rahmani, 1 Faris Alrumaihi, 1 Arwa Essa Alradhi, 2 Amal M Alsubaiyel, 3 Mohammad Algahtani, 4 Rand Mohammad Almousa, 5 Ali Mahzari, 6 Abdulmajeed AA Sindi, 7 Gasim Dobie, 8 Amjad Ali Khan 9 1 Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia; 2 General Administration for Infectious Disease Control, Ministry of Health, Riyadh 12382, Saudi Arabia; 3 Department of Pharmaceutics, College of Pharmacy, Qassim University, Buraydah 51452, Saudi Arabia; 4 Department of Laboratory & Blood Bank, Security Forces Hospital, Mecca 21955, Saudi Arabia; 5 Department of Education, General Directorate of Education, Qassim 52361, Saudi Arabia; 6 Department of Laboratory Medicine, Faculty of Applied Medical Sciences, Al-Baha University, Al-Baha 65527, Saudi Arabia; 7 Department of Basic Medical Sciences, Faculty of Applied Medical Sciences, Al-Baha University, Al-Baha 65527, Saudi Arabia; 8 Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, Jazan University, Gizan 82911, Saudi Arabia; 9 Department of Basic Health Sciences, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia Correspondence: Amjad Ali Khan, Department of Basic Health Sciences, College of Applied Medical Sciences, Qassim University, P.O. Box 6666, Buraydah, 51452, Saudi Arabia, Email The genome editing approach by clustered regularly interspaced short palindromic repeats (CRISPR)/associated protein 9 (CRISPR/Cas9) is a revolutionary advancement in genetic engineering. Owing to its simple design and powerful genome-editing capability, it offers a promising strategy for the treatment of different infectious, metabolic, and genetic diseases. The crystal structure of Streptococcus pyogenes Cas9 (SpCas9) in complex with sgRNA and its target DNA at 2.5 Å resolution reveals a groove accommodating sgRNA:DNA heteroduplex within a bilobate architecture with target recognition (REC) and nuclease (NUC) domains. The presence of a PAM is significantly required for target recognition, R-loop formation, and strand scission. Recently, the spatiotemporal control of CRISPR/Cas9 genome editing has been considerably improved by genetic, chemical, and physical regulatory strategies. The use of genetic modifiers anti-CRISPR proteins, cell-specific promoters, and histone acetyl transferases has uplifted the application of CRISPR/Cas9 as a future-generation genome editing tool. In addition, interventions by chemical control, small-molecule activators, oligonucleotide conjugates and bioresponsive delivery carriers have improved its application in other areas of biological fields. Furthermore, the intermediation of physical control by using heat-, light-, magnetism-, and ultrasound-responsive elements attached to this molecular tool has revolutionized genome editing further. These strategies significantly reduce CRISPR/Cas9's undesirable off-target effects. However, other undesirable effects still offer some challenges for comprehensive clinical translation using this genome-editing approach. In this review, we summarize recent advances in CRISPR/Cas9 structure, mechanistic action, and the role of small-molecule activators, inhibitors, promoters, and physical approaches. Finally, off-target measurement approaches, challenges, future prospects, and clinical applications are discussed. Keywords: CRISPR/Cas9, sgRNA, genome editing, off-target effects, spatiotemporal control, clinical translation Clustered regularly interspaced short palindromic repeats (CRISPR)/associated protein 9 (CRISPR/Cas9) are a class of microbial defense mechanisms against mobile genetic elements, plasmids, and phage infections. 1,2 This endonuclease system has been proposed as an innovative tool for genome editing, genome imaging, epigenetic modulation, and transcriptional perturbation. The genome editing technology by using CRISPR/Cas9 is used to precisely manipulate functional genes involved in disease progression, correct disease-initiating mutations, activate tumor suppressor genes, and inactivate activated oncogenes. 3–5 CRISPR/Cas9 technology can be used to treat a variety of infectious and genetic diseases such as metabolic disorders, cardiovascular diseases, Alzheimer's disease, and human immunodeficiency virus (HIV) infections, 6,7 because of its simple design and ability to simultaneously edit multiple sites. 8 Other DNA editing approaches such as zinc finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs) are also used for -Abstract Truncated-

CAS9 is a genome mutator by directly disrupting DNA-PK dependent DNA repair pathway

Target Interaction of Cas9-sgRNA Influences DNA Double Strand Break Repair Pathway Choices in CRISPR/Cas9 Genome Editing

Target residence of Cas9: challenges and opportunities in genome editing

Target Binding and Residence: a New Determinant of DNA Double-Strand Break Repair Pathway Choice in CRISPR/Cas9 Genome Editing

Programmable DNA Repair with CRISPRa/i Enhanced Homology-Directed Repair Efficiency with a Single Cas9

DNA Repair Pathway Choices in CRISPR-Cas9-Mediated Genome Editing

Cell cycle arrest combined with CDK1 inhibition suppresses genome-wide mutations by activating alternative DNA repair genes during genome editing

Harnessing accurate non-homologous end joining for efficient precise deletion in CRISPR/Cas9-mediated genome editing

Cas9 Exo-Endonuclease Eliminates Chromosomal Translocations During Genome Editing

CRISPR/Cas9 as a Mutagenic Factor

Target residence of Cas9-sgRNA influences DNA double-strand break repair pathway choices in CRISPR/Cas9 genome editing

Proximal binding of dCas9 at a DNA double strand break stimulates homology-directed repair as a local inhibitor of classical non-homologous end joining

Dynamics changes of CRISPR-Cas9 systems induced by high fidelity mutations.

Recent Updates of the CRISPR/Cas9 Genome Editing System: Novel Approaches to Regulate Its Spatiotemporal Control by Genetic and Physicochemical Strategies

The interplay of DNA repair context with target sequence predictably biases Cas9-generated mutations

Quantitative analysis shows that repair of Cas9-induced double-strand DNA breaks is slow and error-prone

Altered DNA repair pathway engagement by engineered CRISPR-Cas9 nucleases

Genome editing with natural and engineered CjCas9 orthologs

Cas9 Has No Exonuclease Activity Resulting in Staggered Cleavage with Overhangs and Predictable Di- and Tri-Nucleotide CRISPR Insertions Without Template Donor

CRISPR/Cas9 for Genome Editing: Progress, Implications and Challenges.

Global Detection of DNA Repair Outcomes Induced by CRISPR-Cas9